Keye Life

开悦生命

Keye Life

Biotech/Healthcare

Shenzhen Kaiyue Life Technology Co., Ltd. was established in March 2016 and mainly engages in the R&D and production of small-molecule inhibitors targeting RNA helicases, for the treatment of human RAS-mutant solid tumors.

Latest round: Pre Series A (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-06-01